Santos Emily, Ciaranello Andrea, Dimitriadis Irene, Attaman Jill, Bebell Lisa M
Brown University, Providence, RI, USA.
Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
BMC Infect Dis. 2025 Feb 19;25(1):240. doi: 10.1186/s12879-025-10618-x.
Maternal cytomegalovirus (CMV) infection at conception can cause congenital CMV (cCMV) infection and substantial morbidity. Although CMV screening is mandated for sperm donors, the risk of acquiring CMV from donor sperm is unknown. Experience with HIV may lead clinicians to expect that standard sperm-washing reduces CMV transmission risk for procedures including intrauterine insemination. However, limited data suggests that CMV may differ importantly from other herpesviruses and from HIV after sperm washing.
A 29-year-old CMV immunoglobulin (Ig)M- and IgG-negative patient underwent intrauterine insemination with a directed donor. The donor was CMV IgM-negative and IgG-positive at the time of donation but had been serum IgM-positive 128 days before donation, and urine CMV PCR-positive 107 days before donation. Following intrauterine insemination, the patient developed clinical evidence of acute CMV infection, CMV viremia, and positive CMV IgM and IgG. The intrauterine insemination did not result in pregnancy. No sources of CMV transmission other than intrauterine insemination could be identified.
Because screening and prevention options for perinatal CMV transmission are limited, a systematic research agenda to understand and reduce CMV transmission risk from seropositive sperm donors is needed to create clear guidelines for fertility treatments and support shared decision-making. Novel approaches to lower risk of transmission from sperm donors with detectable CMV IgG should also be further evaluated. These might include CMV DNA testing of washed sperm samples prior to fertility treatments, antiviral therapy prior to semen collection and/or CMV PCR or IgM screening in pregnant patients who conceived using sperm from antibody-positive donors.
受孕时母体巨细胞病毒(CMV)感染可导致先天性CMV(cCMV)感染及严重发病情况。尽管对精子捐献者强制进行CMV筛查,但通过捐献者精子感染CMV的风险尚不清楚。对HIV的经验可能使临床医生期望标准的精子洗涤能降低包括宫内授精在内的操作中CMV传播风险。然而,有限的数据表明,精子洗涤后CMV可能与其他疱疹病毒及HIV有显著差异。
一名29岁CMV免疫球蛋白(Ig)M和IgG均为阴性的患者接受了定向捐献者的宫内授精。捐献者在捐献时CMV IgM为阴性、IgG为阳性,但在捐献前128天血清IgM为阳性,且在捐献前107天尿液CMV PCR检测为阳性。宫内授精后,该患者出现急性CMV感染、CMV病毒血症的临床证据,且CMV IgM和IgG呈阳性。宫内授精未导致怀孕。除宫内授精外,未发现其他CMV传播源。
由于围产期CMV传播的筛查和预防选择有限,需要一个系统的研究议程来了解和降低血清学阳性精子捐献者的CMV传播风险,以制定明确的生育治疗指南并支持共同决策。还应进一步评估降低可检测到CMV IgG的精子捐献者传播风险的新方法。这些方法可能包括在生育治疗前对洗涤后的精子样本进行CMV DNA检测、在精液采集前进行抗病毒治疗和/或对使用抗体阳性捐献者精子受孕的孕妇进行CMV PCR或IgM筛查。